Article
Mutational footprint of platinum chemotherapy in a secondary thyroid cancer
2022-03-15
Abstract excerpt
Although papillary thyroid carcinoma (PTC) is the most frequent endocrine tumor with a generally excellent prognosis, a patient developed a clinically aggressive PTC eleven years after receiving platinum chemotherapy for ovarian endometrioid adenocarcinoma. Germline and somatic analyses of multi-temporal and multi-regional molecular profiles indicated that ovarian and thyroid tumors did not share common genetic al...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5b5afe31-55a6-59fd-a78a-4652e3d6f9c6
- DOI
- 10.1101/2022.03.14.484002
